An exciting research culture event on 17 October 2025 highlighted an ongoing pilot mentorship programme in the department, developed and led by the Women in Clinical Neurosciences (WICN) group.
Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the University of Oxford and funded by Wellcome.
An interdisciplinary team led by Professor Zameel Cader is part of a major new initiative which aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines.
Professor of Biomedical Engineering Stephen Smith reflects on over 30 years at Oxford University, winning the 2025 Glass Brain Award, and founding FMRIB.
The University of Oxford is to lead a new six-year, \u00a311 million project backed by the Engineering and Physical Sciences Research Council (EPSRC) which aims develop a new generation of personalised treatments capable of reducing or abolishing chronic pain.
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist
A partnership with Clario focuses on advancing the use of wearable sensors to enable more precise measurement of motor symptoms and disease progression in Parkinson's.
This year, thanks to a truly coordinated effort from teams across the department, NDCN has proudly received multiple Bronze, Silver and Gold LEAF awards.
Helen Higham is Director of OxSTaR (Oxford Simulation, Teaching and Research). She was awarded the prestigious Frederic Hewitt Lectureship by the Royal College of Anaesthetists in May 2025 in recognition of her sustained and innovative contributions to human factors, patient safety and simulation-based education.
An ultrasound device that can precisely stimulate areas deep in the brain without surgery has been developed by researchers from NDCN and UCL, opening up new possibilities for neurological research and treatment of disorders such as Parkinson\u2019s disease.
Three pioneering Oxford researchers, including Professor Timothy Behrens from NDCN, are among the first recipients of the Royal Society Faraday Discovery Fellowships, prestigious long-term awards to support exceptional mid-career research leaders in the UK. Only seven academics were selected in total from more than 600 initial applications.
A new paper published in Nature shows how, in a collaborative project across diverse medical disciplines, Oxford researchers from NDCN and the Department of Biochemistry have identified a new genetic link to pain.
A research project led jointly by researchers from NDCN, the University of Copenhagen and University of Cambridge shows that large-scale mapping of prehistoric teeth and bones provides new knowledge of present-day infectious diseases. This may, among other things, have an impact on the development of vaccines.
![\"Masud](\"https://www.ndcn.ox.ac.uk/news/2025_leading-academics-recognised-on-clarivate-highly-cited-list/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n